- It cures hepatitis C pretty darn reliably
- The company that developed it charges something like $100,000 for a treatment regimen.
- All but about $300 of that cost goes to cover Research and Development costs, and profit for the company.
Fortunately, there is a solution here that literally makes everybody happy. The government (the folks that pay for a TON of Hep C treatment already) offers the patent holder a big chunk of cash for the drug patent, and then immediately places it in the public domain. Here are the advantages:
- The drug company is happy, because they get to take their profit for the drug right away.
- Americans with Hepatitis are happy, because they no longer have Hepatitis.
- Overall cost of healthcare in the country goes down, because fewer people have liver cancer and cirrhosis.
notes on the actual costs associated:
Total value of Gilead (owner of Sofosbuvir patents) ~150 Billion, as of this writing
They have a pretty big portfolio of drugs, so lets guess that the value of the sofosbuvir patents is about half their value as a company, or about 75 Billion.
Number of people with Hep C in the USA is roughly 2.7 Million
If the government paid 75 Billion to buy the patent and make it public domain, the cost works out to about $28,000 per cure.
Seriously, this is a no-brainer. We can more or less cure Hep C in America for $28,000 per cure, which doesn't even count the benefit of basically eliminating future infections. The only catch is that it requires big government intervention.
YES. everything about this post.
ReplyDeleteLike ur analysis but it is not going to happen unfortunately. This drug may be available lot cheaper in Canada or Mexico or in Europe. Need to check this out.
ReplyDelete